Peter Thiel reports 5.3% stake in AbCellera Bio
- AbCellera Biologics (NASDAQ:ABCL) perks 2% premarket after Peter Thiel discloses 5.3% stake or holding of ~14.36M shares of the company.
- Mr. Thiel serves as a board member of the company and will be involved in reviewing transactions that may result in operational, strategic, financial or governance changes.
- The common shares reported in this filing have been acquired for investment purposes.
- SC 13D
- https://seekingalpha.com/news/3647635-peter-thiel-reports-5_3-stake-in-abcellera-bio
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.